These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6119772)

  • 21. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG; Hansky J; Eaves ER; Schmidt GT
    Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
    Sasaki M; Sudoh T; Fujimura A
    Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
    Meryn S; Pötzi R; Brunner H; Pesendorfer FX; Pamperl H
    Wien Klin Wochenschr; 1983 Apr; 95(9):310-2. PubMed ID: 6137111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
    Sevvel S; Ananthakrishnan N; Kate V
    Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ranitidine in the treatment of acute upper gastrointestinal haemorrhage--a comparative study. Preliminary report.
    Nowak A; Sadliński C; Górka Z; Nowakowska E; Rudzki J; Gibiński K
    Hepatogastroenterology; 1981 Oct; 28(5):267-9. PubMed ID: 6124495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
    Matov V; Metchkov G; Krastev Z; Tchernev K; Mitova R; Márquez M; Torres J; Herrero E; Fillat O; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
    Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranitidine and duodenal ulceration: a short-term and maintenance study.
    Sheers R; McKay JS; Hughes S
    J R Soc Med; 1982 May; 75(5):323-6. PubMed ID: 6122738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral ranitidine for prophylaxis against Mendelson's syndrome.
    Francis RN; Kwik RS
    Anesth Analg; 1982 Feb; 61(2):130-2. PubMed ID: 6119931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of ranitidine on prognosis after simple closure of perforated duodenal ulcer.
    Singh K; Chhina RS; Ghosh A; Kaura R
    Trop Gastroenterol; 1999; 20(2):90-2. PubMed ID: 10484900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roxatidine in duodenal ulcer.
    Habibullah CM; Habeeb MA; Singh SP
    J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative efficacy of ranitidine and cimetidine in the short-term treatment of duodenal ulcer (results of an international controlled trial)].
    Laverdant C
    Gastroenterol Clin Biol; 1983 May; 7(5):480-6. PubMed ID: 6135643
    [No Abstract]   [Full Text] [Related]  

  • 38. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
    Giacosa A; Cheli R; Molinari F; Parodi MC
    Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
    Gabryelewicz A; Sarosiek J; Laszewicz W
    Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.